pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
OCX-909
Glioblastoma Multiforme (GBM)
$OCEA
Ocean Biomedical, Inc.
0
catalysts
Preclinical
OKI-345
Breast Cancer
$OKUR
OnKure Therapeutics, Inc.
0
catalysts
Preclinical
OM-301
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Oncolyze Inc
0
catalysts
Phase 2
OMO-1
← prev
page 29 of 62
next →
131
Pain
89
Neurology
1
Solid Tumor
DeuterOncology NV
0
catalysts
Phase 2
ONC-841
Colorectal Cancer
OncoC4 Inc
0
catalysts
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMA
Olema Pharmaceuticals, Inc.
0
catalysts
Preclinical
OPB-171775
Gastrointestinal Stromal Tumor (GIST)
$BDRX
Biodexa Pharmaceuticals Plc
0
catalysts
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
0
catalysts
Preclinical
OPTF-01
Glioblastoma Multiforme (GBM)
Optieum Biotechnologies Inc
0
catalysts
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
0
catalysts
Preclinical
OR-449
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Orphagen Pharmaceuticals Inc
0
catalysts
Preclinical
ORG-101
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
Orgenesis Inc
0
catalysts
Phase 3
OSE-2101
Tedopi
Non-Small Cell Lung Cancer
OSE Immunotherapeutics SA
0
catalysts
Phase 1
OTS-167
Metastatic Breast Cancer
OncoTherapy Science Inc
0
catalysts
Phase 2
OXI-4503
Refractory Acute Myeloid Leukemia
$OTLC
Oncotelic Therapeutics, Inc.
0
catalysts
Phase 3
OncoVAX
Colon Cancer
Vaccinogen Inc
0
catalysts
Preclinical
Oncolipin-IT
Colorectal Cancer
XEME BioPharma Inc
0
catalysts
Preclinical
Oncoplex
Glioblastoma Multiforme (GBM)
$PYPD
PolyPid Ltd.
0
catalysts
Phase 1
Oncoquest
Chronic Lymphocytic Leukemia (CLL)
XEME BioPharma Inc
0
catalysts
Marketed
Oncotice
Tice BCG
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$MRK
Merck & Co., Inc.
0
catalysts
Marketed
Opzelura
Opzelura (ruxolitinib phosphate)
Hidradenitis Suppurativa
Tyrosine-protein kinase JAK1
Tyrosine-protein kinase JAK2
$INCY
INCYTE CORP
0
catalysts
Phase 2
OriCAR-017
Refractory Multiple Myeloma
Oricell Therapeutics (Shanghai) Co Ltd
0
catalysts
Preclinical
Oxy-210
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
Max Biopharma Inc
0
catalysts
Phase 1
P-01
Pancreatic Cancer
Hangzhou Neoantigen Therapeutics Co Ltd
0
catalysts
Phase 1
PAS-004
Plexiform Neurofibroma
$KTTA
Pasithea Therapeutics Corp.
0
catalysts
Phase 2
PAX-1
Bile Duct Cancer (Cholangiocarcinoma)
Komipharm International Co Ltd
0
catalysts
phase_0
PBA-0111
Alveolar Soft Part Sarcoma (ASPS)
Pure Biologics SA
0
catalysts
phase_0
PBA-0405
Alveolar Soft Part Sarcoma (ASPS)
Pure Biologics SA
0
catalysts
Phase 1
PBCAR-19B
Diffuse Large B-Cell Lymphoma
$DTIL
PRECISION BIOSCIENCES INC
0
catalysts
Phase 2
PBI-05204
Metastatic Adenocarcinoma of The Pancreas
Phoenix Biotechnology Inc
0
catalysts
